Zwitterionic lipid design enhances mRNA cancer vaccine efficacy and reduces reactogenicity

Zwitterionic lipid design enhances mRNA cancer vaccine efficacy and reduces reactogenicity

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This is a summary of: Zhao, Y. et al. Low reactogenicity and high tumour antigen expression from mRNA-LNPs with membrane-destabilizing zwitterionic lipids. Nat. Biomed. Eng. https://doi.org/10.1038/s41551-025-01577-4 (2025).